News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

Clinical Trial Alert: Amicus Therapeutics Seeks Participants for a Phase 3 Late-Onset Pompe Disease Study

By MDA Staff | October 16, 2019
Blog Post

Clinical Trial Alert: Momenta Pharmaceuticals Seeks Participants for a Phase 2 Myasthenia Gravis Study

By MDA Staff | October 15, 2019
Blog Post

Casey’s General Stores Round Up for MDA

By MDA Staff | October 15, 2019
Blog Post

NS Pharma Submits New Drug Application to FDA for Viltolarsen to Treat DMD Amenable to Exon 53 Skipping

By Jeanene Swanson | October 7, 2019
Blog Post

MDA Awards Clinical Research Network Grant to CMT Researcher Michael Shy for Inherited Neuropathies Consortium

By Jeanene Swanson | September 27, 2019
MDA logo
Blog Post

In a Letter to the Duchenne Community, Santhera Announces Positive Results of Phase 2 Vamorolone Study, EMA’s Review of Puldysa to Treat Symptoms of DMD

By MDA Staff | September 26, 2019
Blog Post

MDA Awards 25 Grants Totaling More Than $6.6 Million for Neuromuscular Disease Research

By Jeanene Swanson | September 5, 2019
baby girl
Blog Post

Biogen Announces Positive Long-Term Results from Phase 2 Study of Spinraza to Treat SMA in Pre-Symptomatic Infants

By Jeanene Swanson | August 21, 2019
Blog Post

The ALS Association, ALS Finding A Cure, and MDA Co-Fund Clinical Trial Grant to Study Restoring Immune System Function to Treat ALS

By Jeanene Swanson | August 9, 2019
Blog Post

Scholar Rock Announces Positive Results from Phase 1 Study of SRK-015 to Treat SMA

By Jeanene Swanson | August 7, 2019